Timothy Moore
Cardiovascular Disease · Boise, IDNPI 1124064423
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 60 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 19.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,176 and has fallen 91.4% since, to $101 in 2025.
Across 60 payments — averaging $47.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$563
- Abbott$461
- E.r. Squibb & Sons, L.L.C.$290
- Alnylam Pharmaceuticals Inc.$286
- Novartis$216
- Biotronik Inc.$161
- plus $890 from 14 others
What the payments were for
- Food & beverage$2,83499%
- Education$331%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 7 | $563 |
| Abbott | 3 | $461 |
| E.r. Squibb & Sons, L.L.C. | 9 | $290 |
| Alnylam Pharmaceuticals Inc. | 3 | $286 |
| Novartis | 9 | $216 |
| Biotronik Inc. | 7 | $161 |
| Actelion Pharmaceuticals US, Inc. | 2 | $134 |
| AstraZeneca | 2 | $116 |
| Esperion Therapeutics, Inc. | 1 | $113 |
| Atricure, Inc. | 1 | $98 |
| Regeneron Healthcare Solutions, Inc. | 1 | $88 |
| Pfizer | 5 | $73 |
| Sanofi-aventis U.S. LLC | 2 | $72 |
| Irhythm Technologies, Inc. | 1 | $67 |
| Medtronic | 2 | $55 |
| Organogenesis Inc. | 1 | $24 |
| Amgen | 1 | $14 |
| Johnson & Johnson | 1 | $12 |
| Preventice Services, LLC | 1 | $12 |
| United Therapeutics Corporation | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ELIQUIS$215
- AMVUTTRA$202
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$179
- MitraClip System$164
- LifeVest$135
- CardioMEMS HF System$118
- NEXLIZET$113
- NEXLETOL$113
- ENTRESTO$108
- FARXIGA$105
How this compares
$2,867 in reported general payments places this provider in the 55th percentile of 59 cardiovascular disease providers in Idaho.
Other cardiovascular disease in Boise
- David HinchmanBoise$324K
- Robyn BrydeBoise$27K
- Matthew NelsonBoise$6K
- Beth MalaskyBoise$5K
- Stefanie FryBoise$4K
- Samual BassBoise$4K
- Michael RichBoise$2K
- Troy BadgerBoise$2K
- Jon BergsetBoise$636
- Steven FonkenBoise$598
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.